A novel therapeutic anti-HBV antibody with increased binding to human FcRn improves in vivo PK in mice and monkeys.

ABSTRACT:

SUBMITTER: Kang C 

PROVIDER: S-EPMC5777975 | biostudies-literature | 2018 Jan

REPOSITORIES: biostudies-literature